Aptinyx Inc.

Aptinyx Inc.verified

APTX

Price:

$0.096

Market Cap:

$0

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase II/b clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase II clinical study for the treatment of Parkinson's di...[Read more]

Industry

Biotechnology

IPO Date

2018-06-21

Stock Exchange

NASDAQ

Ticker

APTX

The Current Ratio as of December 2024 (TTM) for Aptinyx Inc. (APTX) is 10.18

According to Aptinyx Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.18. This represents a change of -30.96% compared to the average of 14.74 of the last 4 quarters.

Aptinyx Inc. (APTX) Historical Current Ratio (quarterly & annually)

How has APTX Current Ratio performed in the past?

The mean historical Current Ratio of Aptinyx Inc. over the last ten years is 19.44. The current 10.18 Current Ratio has changed 5.14% with respect to the historical average. Over the past ten years (40 quarters), APTX's Current Ratio was at its highest in in the June 2021 quarter at 39.56. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

19.44

Median

21.47

Minimum

3.80

Maximum

32.64

Aptinyx Inc. (APTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aptinyx Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 472.20%

Maximum Annual Current Ratio = 32.64

Minimum Annual Increase = -49.56%

Minimum Annual Current Ratio = 3.80

Quarterly (TTM)
Annual
YearCurrent RatioChange
202210.18-49.56%
202120.18-38.18%
202032.6452.05%
201921.47-17.56%
201826.0419.80%
201721.74472.20%

Aptinyx Inc. (APTX) Average Current Ratio

How has APTX Current Ratio performed in the past?

The current Current Ratio of Aptinyx Inc. (APTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

21.00

5-year avg

22.10

10-year avg

19.44

Aptinyx Inc. (APTX) Current Ratio vs. Peers

How is APTX’s Current Ratio compared to its peers?

Aptinyx Inc.’s Current Ratio is greater than Evelo Biosciences, Inc. (0.48), less than Magenta Therapeutics, Inc. (14.64), greater than Aileron Therapeutics, Inc. (3.30), greater than ABVC BioPharma, Inc. (0.34), less than Neoleukin Therapeutics, Inc. (15.33), greater than CytomX Therapeutics, Inc. (1.04), greater than Assembly Biosciences, Inc. (2.36), less than Instil Bio, Inc. (12.90), greater than Nuvation Bio Inc. (9.57), greater than Allarity Therapeutics, Inc. (2.75), greater than NeuroBo Pharmaceuticals, Inc. (2.41), greater than Hillstream BioPharma, Inc. (2.25), less than Virax Biolabs Group Limited (25.94), greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than Spero Therapeutics, Inc. (2.68), greater than Achilles Therapeutics plc (6.04), greater than Adial Pharmaceuticals, Inc. (6.78), greater than TransCode Therapeutics, Inc. (1.58), greater than Aditxt, Inc. (0.09), greater than Reviva Pharmaceuticals Holdings, Inc. (0.39), greater than Avenue Therapeutics, Inc. (2.70),

Build a custom stock screener for Aptinyx Inc. (APTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptinyx Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptinyx Inc. (APTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptinyx Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Aptinyx Inc.'s Current Ratio?

How is the Current Ratio calculated for Aptinyx Inc. (APTX)?

What is the highest Current Ratio for Aptinyx Inc. (APTX)?

What is the 3-year average Current Ratio for Aptinyx Inc. (APTX)?

What is the 5-year average Current Ratio for Aptinyx Inc. (APTX)?

How does the current Current Ratio for Aptinyx Inc. (APTX) compare to its historical average?